Scientific Resources
Our next-generation diagnostic assays have generated novel insights across a broad range of clinical applications.
Access our presentations, publications, and more to see how we’re unlocking the full potential of precision genomics.
Found 29 Results
Escalating Doses of AZD0486, a Novel CD19xCD3 T-cell Engager, Result in High Complete Remissions with Rapid Clearance of Minimal Residual Disease in Patients with Relapsed/Refractory Follicular Lymphoma
December 17, 2024 | Presentation
Mosunetuzumab Plus Polatuzumab Vedotin Induces Early Complete Responses in Previously Untreated High Tumor Burden Follicular Lymphoma
December 13, 2024 | Poster
Circulating tumor DNA clearance by neoadjuvant chemotherapy or breast surgery detected using an ultra-sensitive ctDNA MRD assay in early breast cancer
December 13, 2024 | Poster
Baseline prognostic factors do not predict end of treatment ctDNA MRD status and have limited impact on MRD prognostic performance in DLBCL
December 12, 2024 | Presentation
High rates of undetectable MRD by PhasED-Seq on interim and end of treatment timepoints in untreated advanced stage CHL treated with pembrolizumab + AVD
December 12, 2024 | Poster
Ultra-sensitive ctDNA detection and monitoring in early breast cancer using PhasED-Seq
September 16, 2024 | Poster